Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Nakachi

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Oncoimmunology|July 29, 2016
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patientsYu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2021
Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir TreatmentNoriyuki Akutsu, Shigeru Sasaki, Takeshi Matsui, et al.
Journal of Surgical Oncology|January 27, 2026
Original Study: Risk Factors for Early Recurrence in Patients With Biliary Tract Cancers Who Underwent Curative Resection: An Exploratory Subgroup Analysis of JCOG1202Hiroaki Yanagimoto, Kohei Nakachi, Masafumi Ikeda, et al.
Journal of Gastroenterology|April 15, 2014
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled studyKiwamu Okita, Namiki Izumi, Osamu Matsui, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi, et al.
Journal of Gastroenterology|November 30, 2024
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weightingHiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, et al.
Journal of Gastroenterology|September 6, 2025
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)Satoshi Kobayashi, Kohei Nakachi, Kouji Yamamoto, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Oncoimmunology|July 29, 2016
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patientsYu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2021
Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir TreatmentNoriyuki Akutsu, Shigeru Sasaki, Takeshi Matsui, et al.
Journal of Surgical Oncology|January 27, 2026
Original Study: Risk Factors for Early Recurrence in Patients With Biliary Tract Cancers Who Underwent Curative Resection: An Exploratory Subgroup Analysis of JCOG1202Hiroaki Yanagimoto, Kohei Nakachi, Masafumi Ikeda, et al.
Journal of Gastroenterology|April 15, 2014
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled studyKiwamu Okita, Namiki Izumi, Osamu Matsui, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi, et al.
Journal of Gastroenterology|November 30, 2024
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weightingHiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, et al.
Journal of Gastroenterology|September 6, 2025
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)Satoshi Kobayashi, Kohei Nakachi, Kouji Yamamoto, et al.
Pageof 5